Schnitzer TJ, et al. Efficacy and Safety of Subcutaneous Tanezumab for the Treatment of Osteoarthritis of the Hip or Knee. ACR 2018, abstract L20.
Risico op hart- en vaatziekten bij inflammatoire artritis verhoogd
jan 2024 | Arthritis psoriatica, RA, Spondyloartritis